United States · FDA National Drug Code directory
Ondansetron Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85766-053_502ee59f-cd7a-80c0-e063-6394a90acba4
- Product NDC
- 85766-053
- Form
- TABLET, FILM COATED
- Composition / generic term
- Ondansetron Hydrochloride
- Labeler
- Sportpharm LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070731
- Source listing expiry
- 20271231
Source-listed ingredients
- ONDANSETRON HYDROCHLORIDE — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 5 TABLET, FILM COATED in 1 BOTTLE (85766-053-05) · 85766-053-05
- 10 TABLET, FILM COATED in 1 BOTTLE (85766-053-10) · 85766-053-10
- 14 TABLET, FILM COATED in 1 BOTTLE (85766-053-14) · 85766-053-14
- 20 TABLET, FILM COATED in 1 BOTTLE (85766-053-20) · 85766-053-20
- 24 TABLET, FILM COATED in 1 BOTTLE (85766-053-24) · 85766-053-24
- 30 TABLET, FILM COATED in 1 BOTTLE (85766-053-30) · 85766-053-30
- 60 TABLET, FILM COATED in 1 BOTTLE (85766-053-60) · 85766-053-60
- 90 TABLET, FILM COATED in 1 BOTTLE (85766-053-90) · 85766-053-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →